177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Shanghai Zhongshan Hospital
Radboud University Medical Center
Haukeland University Hospital
Technische Universität Dresden
The First Affiliated Hospital with Nanjing Medical University
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Fudan University
Duke University
Centre Leon Berard
China Medical University, China
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Icahn School of Medicine at Mount Sinai
Sun Yat-sen University
Fudan University
Chinese PLA General Hospital
Peter MacCallum Cancer Centre, Australia
Hunan Province Tumor Hospital
Shanxi Province Cancer Hospital
Soonchunhyang University Hospital
Zhejiang University
Leiden University Medical Center
Chinese PLA General Hospital
University of Saskatchewan
University Hospital, Linkoeping
University of California, Davis
Shouyao Holdings (Beijing) Co. LTD
Institute of Hematology & Blood Diseases Hospital, China
Korean Cancer Study Group
Instituto Venezolano de Investigaciones Cientificas
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Peking University People's Hospital
Keio University
Xuanwu Hospital, Beijing
Seoul St. Mary's Hospital
First Affiliated Hospital of Fujian Medical University
First Affiliated Hospital of Fujian Medical University
Peking Union Medical College Hospital
Jiangxi University of Traditional Chinese Medicine
Sunnybrook Health Sciences Centre
Changhai Hospital
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Affiliated Hospital of Nantong University
Fudan University
Tianjin Medical University Cancer Institute and Hospital
Peking Union Medical College Hospital
Second Affiliated Hospital of Guangzhou Medical University
The Second Affiliated Hospital of Kunming Medical University